KIMBERLY PAIR: Open Payments
NPI 1982913026 · BOSSIER CITY, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$126 in 8 payments from 6 companies in 2025. Trend: 2023 $62 · 2024 $157 · 2025 $126
Food & beverage: $126
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 2 | $32 |
| AstraZeneca Pharmaceuticals LP | 2 | $32 |
| ABBVIE INC. | 1 | $18 |
| Lilly USA, LLC | 1 | $15 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $15 |
| Astellas Pharma US Inc | 1 | $14 |
Products named: Wegovy, AIRSUPRA, CREON, MOUNJARO, XIFAXAN, Veozah.
Industry payments across LA — which companies pay providers there.
